VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LENZ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LENZLENZ Therapeutics, Inc.
$5.90$185M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLENZQuarterly Financials

LENZ Therapeutics, Inc. (LENZ) Quarterly Financials

120+ quarters historyFree accessUpdated daily

LENZ Therapeutics, Inc. (LENZ) quarterly income statement — complete revenue, gross profit & net income history

LENZ Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.9M1.59M12.5M5M0000000000000000
Revenue Growth %--------------------
Cost of Goods Sold1.19M525K125K19K36K0000000002.17M2.06M1.89M0556K100K
COGS % of Revenue62.44%33.06%1%0.38%----------------
Gross Profit714K1.06M12.38M4.98M-36K000000000-2.17M-2.06M-1.89M0-556K-100K
Gross Margin %37.56%66.94%99%99.62%----------------
Gross Profit Growth %2083.33%---------100%100%100%--289.93%-1964%-2002.22%100%--
Operating Expenses44.85M39.53M31.26M21.84M16.89M15.22M12.95M14.35M16.09M24.99M19.86M14.96M12.62M9.13M23.99M24.71M24.07M18.94M14.05M17.43M
OpEx % of Revenue2359.23%2489.04%250.1%436.76%----------------
Selling, General & Admin44.85M39.53M27.47M12.78M11.08M9.36M6.49M7.41M5.55M5.45M2.86M2.32M2.29M1.5M7.85M6.93M5.82M7.74M5.36M4.77M
SG&A % of Revenue2359.23%2489.04%219.77%255.54%----------------
Research & Development003.79M9.06M5.82M5.87M6.45M6.95M10.54M19.54M17M12.64M10.32M7.63M16.13M17.78M18.25M11.21M8.68M12.67M
R&D % of Revenue--30.33%181.22%----------------
Other Operating Expenses00000000000000000000
Operating Income-44.13M-38.46M-18.89M-16.86M-16.93M-15.22M-12.95M-14.35M-16.09M-24.99M-19.86M-14.96M-12.62M-9.13M-26.15M-26.78M-25.96M-18.94M-14.6M-17.53M
Operating Margin %-2321.67%-2422.1%-151.1%-337.14%----------------
Operating Income Growth %-160.68%-152.63%-45.9%-17.45%-5.24%39.07%34.84%4.06%-27.52%-173.79%24.05%44.13%51.4%51.81%-79.11%-52.72%-177.09%-127.56%--
EBITDA-44.02M-38.36M-18.76M-16.84M-16.89M-15.2M-12.94M-14.33M-16.08M-24.98M-19.86M-14.96M-12.61M-9.12M-23.99M-24.71M-24.07M-18.93M-14.05M-17.43M
EBITDA Margin %-2315.83%-2415.37%-150.1%-336.76%----------------
EBITDA Growth %-160.57%-152.34%-45.05%-17.47%-5.05%39.16%34.87%4.15%-27.51%-173.84%17.2%39.48%47.59%51.8%-70.77%-41.75%-159.39%-130.8%--
D&A (Non-Cash Add-back)111K107K125K19K36K25K10K18K5K4K4K4K3K3K2.17M2.06M1.89M0556K100K
EBIT-44.13M-38.46M-18.89M-16.86M-16.93M-15.22M-12.95M-14.35M-16.09M-24.99M-19.86M-14.96M-12.62M-9.13M-24.68M-26.66M-26.14M-18.93M-14.59M-17.53M
Net Interest Income2.64M2.99M2.2M2.25M2.32M2.57M2.74M2.46M788K01.09M251K001.47M00000
Interest Income2.64M2.99M2.2M2.25M2.32M2.57M2.74M2.46M788K01.09M251K001.47M00000
Interest Expense00000000000000000000
Other Income/Expense2.65M2.57M2.19M2.44M2.31M2.57M2.73M4.1M-560K1.12M985K233K-54K1K1.47M116K-186K10K10K4K
Pretax Income-41.49M-35.89M-16.7M-14.41M-14.62M-12.65M-10.21M-10.25M-16.65M-23.87M-18.88M-14.73M-12.67M-9.13M-24.68M-26.66M-26.14M-18.93M-14.59M-17.53M
Pretax Margin %-2182.43%-2260.33%-133.6%-288.24%----------------
Income Tax02K0500K01K000-179K000303K000000
Effective Tax Rate %0%-0.01%0%-3.47%0%-0.01%0%0%0%0.75%0%0%0%-3.32%0%0%0%0%0%0%
Net Income-41.49M-35.9M-16.7M-14.91M-14.62M-12.65M-10.21M-10.25M-16.65M-23.69M-18.88M-14.73M-12.67M-9.43M-24.68M-26.66M-26.14M-18.93M-14.59M-17.53M
Net Margin %-2182.43%-2260.45%-133.6%-298.24%----------------
Net Income Growth %-183.8%-183.72%-63.49%-45.43%12.19%46.6%45.9%30.37%-31.4%-151.27%23.51%44.76%51.54%50.19%-69.15%-52.09%-32.65%70.21%--
Net Income (Continuing)-41.49M-35.9M-16.7M-14.91M-14.62M-12.65M-10.21M-10.25M-16.65M-23.69M-18.88M-14.73M-12.67M-9.43M-24.68M-26.66M-26.14M-18.93M-14.59M-17.53M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.32-1.16-0.59-0.53-0.53-0.46-0.38-0.40-3.53-2.77-2.75-6.82-3.00-3.09-3.13-3.42-3.39-2.28-1.76-2.19
EPS Growth %-149.06%-152.17%-55.26%-32.5%84.99%83.39%86.18%94.13%-17.67%10.36%12.14%-99.42%11.5%-35.53%-77.84%-56.16%-42.44%70.23%--
EPS (Basic)-1.32-1.16-0.59-0.53-0.53-0.46-0.38-0.40-3.53-2.77-2.75-6.82-3.00-3.09-3.13-3.42-3.39-2.28-1.76-2.19
Diluted Shares Outstanding31.35M31.07M28.54M28.08M27.53M27.49M27.17M25.61M4.72M8.29M8.18M8.11M7.98M7.96M7.89M7.8M7.72M8.29M8.3M8M
Basic Shares Outstanding31.35M31.07M28.54M28.08M27.53M27.49M27.17M25.61M4.72M8.29M8.18M8.11M7.98M7.96M7.89M7.8M7.72M8.29M8.3M8M
Dividend Payout Ratio--------------------